Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies

NCT01634880 is registered in ClinicalTrials.gov with Athanassios Argiris as lead sponsor.

NCT NCT01634880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01634880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Postoperative Radiotherapy and Panitumumab in High-Risk Salivary Gland Malignancies
Lead sponsor
Athanassios Argiris
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2012
Completion date
March 31, 2013
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

salivary gland malignancy